These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 15252425

  • 21. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.
    J Natl Cancer Inst; 2008 Apr 02; 100(7):462-74. PubMed ID: 18364506
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 25. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Yoshida M, Hagiwara Y, Inoue K, Tabei T.
    Breast J; 2006 Oct 01; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Implications of a postoperative rehabilitation program on quality of life in women with primary breast cancer treated with sentinel lymph node biopsy or complete axillary lymph node dissection.
    Pinto e Silva MP, Sarian LO, Morais SS, Pace do Amaral MT, Freire de Oliveira MM, Derchain S.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3342-9. PubMed ID: 18931880
    [Abstract] [Full Text] [Related]

  • 28. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
    Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ.
    Ann Surg Oncol; 2006 Nov 01; 13(11):1450-6. PubMed ID: 17009150
    [Abstract] [Full Text] [Related]

  • 29. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU.
    Eur J Surg Oncol; 2006 Mar 01; 32(2):148-52. PubMed ID: 16387467
    [Abstract] [Full Text] [Related]

  • 30. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
    Golshan M, Martin WJ, Dowlatshahi K.
    Am Surg; 2003 Mar 01; 69(3):209-11; discussion 212. PubMed ID: 12678476
    [Abstract] [Full Text] [Related]

  • 31. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA.
    Eur J Surg Oncol; 2009 Feb 01; 35(2):159-63. PubMed ID: 18789841
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
    Langer I, Kocher T, Guller U, Torhorst J, Oertli D, Harder F, Zuber M.
    Breast Cancer Res Treat; 2005 Mar 01; 90(1):85-91. PubMed ID: 15770531
    [Abstract] [Full Text] [Related]

  • 35. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK, Dauphine CE, Vargas MP, Gonzalez K, Burla M, Kaufmann P, Vargas HI.
    Am Surg; 2006 Oct 01; 72(10):939-42. PubMed ID: 17058740
    [Abstract] [Full Text] [Related]

  • 36. Sentinel lymph node biopsy in breast cancer: scientific rationale and patient care.
    Zack E.
    Oncol Nurs Forum; 2001 Jul 01; 28(6):997-1005; quiz 1006-7. PubMed ID: 11475886
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.
    Eur J Surg Oncol; 2009 Aug 01; 35(8):805-13. PubMed ID: 19046846
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
    Gui GP, Joubert DJ, Reichert R, Ward A, Lakhani S, Osin P, Nerurkar A, A'Hern R, Benson K, Underwood SR.
    Eur J Surg Oncol; 2005 Sep 01; 31(7):707-14. PubMed ID: 15993028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.